OnCo

Stay in the loop

Leave your email and OnCo will write when something big changes in cancer research. No spam, one click to unsubscribe.

Email updates open shortly. Until then, press Watch on any page to keep it on your list.

Oral cavity cancer (mouth and tongue): lines of therapy

Cancer page →

5 standard-of-care settings across 4 lines and 2 biomarker subgroups. Rows come from the cancer page's standard of care; the grid places each on its line and subgroup.

LineAll comersRisk group
Screening, prevention and diagnosis11
Early / localised1·
Locally advanced1·
Advanced, first line1·

Screening, prevention and diagnosis

SubgroupSettingApproachProducts and trialsEvidence
All comersPreventionTobacco and betel quid cessation, alcohol reduction, treatment of premalignant patches.32
Risk groupScreening in high-risk populationsVisual oral examination by trained workers reduced mouth cancer deaths in the Kerala trial; opportunistic examination by dentists elsewhere.-

Early / localised

SubgroupSettingApproachProducts and trialsEvidence
All comersEarly diseaseWide excision with elective neck dissection when depth of invasion exceeds about 3 to 4 mm; sentinel node biopsy in selected cases.-

Locally advanced

SubgroupSettingApproachProducts and trialsEvidence
All comersLocally advanced diseaseResection with neck dissection and free-flap reconstruction, then postoperative radiotherapy, or cisplatin chemoradiation for positive margins or extranodal extension.93

Advanced, first line

SubgroupSettingApproachProducts and trialsEvidence
All comersRecurrent or metastaticPembrolizumab with or without chemotherapy (KEYNOTE-048); low-cost metronomic methotrexate and celecoxib where access is limited.98

Lines and subgroups are parsed from the setting text of each standard-of-care row and can misclassify an unusual phrasing; the row’s own setting is always shown. Guideline chips reflect the NCCN category and ESMO-MCBS grade recorded on the cancer page, checked on its stated date. Not medical advice.